Alexa, What is Eliquis and Xarelto?
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Enrollment
- 36
- Locations
- 2
- Primary Endpoint
- % Change in pre- and post test scores
Study Overview
Brief Summary
The purpose of this study is to evaluate the effectiveness of providing patient medication education about Eliquis and Xarelto through an Amazon Alexa based voice recording.
Detailed Description
Anticoagulants are considered high-risk medications due to the risk of major bleeding. The Federal Drug and Food Administration (FDA) MedWatch reporting system found that anticoagulants had the most adverse drug event (ADE) reports in 2011. Anticoagulants have also been reported as one of the leading drug classes contributing to emergency department visits3. Given the potential for serious adverse events, providing effective education to increase patient knowledge and awareness of those risks are essential. Incorporating technology into health care is becoming increasingly popular and has been shown to be effective for patient education. One reason is that technology can consistently provide complete patient education and is not subject to educator variability in providing this education.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients will be excluded if they have documented altered mental status, do not speak English, or are being prescribed rivaroxaban or apixaban on discharge only.
- •Nurses will be excluded if not providing direct patient care in select general medicine and orthopedic surgical units
- •Nurses declining participation
Outcomes
Primary Outcomes
% Change in pre- and post test scores
Time Frame: Within 72 hours of education
Effectiveness of Alexa based education by assessing understanding of Eliquis and Xarelto pre and post Alexa education
Secondary Outcomes
- 7-day post-education retention rate(1 week post discharge)
- Patient satisfaction(72 hours)
- Nursing satisfaction(72 hours)
Investigators
Kaman Chung
Pharmacy Manager
Cedars-Sinai Medical Center